Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Establishing wealth accumulation goals is essential for retirement. Learn how to set effective targets to secure your financial freedom.
12,107 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Memory-chip demand remains tight, and Micron's product mix positions it to benefit from AI adoption in data centers. ...
As policy changes from lenders and the GSEs take shape, mortgage markets face a potential major shift in credit alloc...
A federal judge blocked the Trump-era SNAP limits on soda and candy, delaying a controversial nutrition policy that w...
SpaceX has fallen roughly a third from its peak, sparking questions about its trajectory. This article outlines four ...
A diversified cybersecurity ETF now holds CrowdStrike alongside 30 other rivals, offering broad exposure as AI-driven...
ServiceNow has built a durable software platform with strong margins and steady growth. This article explains why the...
In a crowded crypto landscape, Ethereum still stands out for three core reasons. From its mature smart contract ecosy...
Stablecoins aim to hold a steady value, but a stablecoin crash? can ripple through portfolios. Learn how pegs work, w...
UnitedHealth stock quietly soared about 80% off its 2025 low, signaling a meaningful rebound. This article dives into...
AI momentum has shifted, and Cerebras stock's volatility comes into sharper focus for investors. This guide breaks do...
Ford shifts AI strategy by adding 350 veteran engineers to steer its tools, citing early limits of automation and a r...